President

Developer of oral, gut-targeted polymer therapeutics for the treatment of metabolic indications such as type 2 diabetes, and other chronic conditions. The company is developing a lead drug, which is orally administered, non-absorbed, gut-restricted duodenal exclusion therapy designed to replicate the metabolic effects of bariatric surgery with safety-advantages avoiding invasive complications of surgeries and procedures.

Glyscend Therapeutics

Independent Consultant

Senior Scientist

Staff Scientist 2 - Senior Scientist

Supervisor of Animal Research - Staff Scientist 1

Co-Founder, Chief Scientific Officer

Scientific Founder

Principal

VP, Biomaterials Science & Engineering

Senior Director, Medicinal Chemistry

Principal Scientist

VP CMC

Sr. Director CMC

VP Research & Development

Vice President Chemistry Manufacturing

Sr Director Manufacturing

Director Manufacturing

Director Waters Chemical Products R&D

Senior Investment Manager

Alternate Director

Director

Investment Manager

Investment Associate

Board Observer

Acting Chief Executive Officer

Examiner, Demonstrator

Department of Surgery (Neurosurgery)

Research Scientist

Graduate Teaching Assistant

Graduate Research Assistant | Project Management

Research Intern | Time Managment

CRLA CERTIFIED TUTOR

International Research Intern | International Experience and Cultural Immersion

Undergraduate Researcher | Advanced Organic Chemistry Techniques

Undergraduate Researcher | Advanced Analytical Chemistry Techniques

Chief Executive Officer

Founder & CEO

Independent Consultant/Acting CEO

Entrepreneur In Residence

Founder, Chief Medical Officer and Head of R&D

Technology Value Analysis Committee Member

Medical Director

Assistant Professor of Technology Entrepreneurship

Assistant Professor of Medicine, Division of Gastroenterology & Hepatology

Founder & Chief Executive Officer

Biodesign (Medical Technology) Innovation Fellow

Faculty, Department of Medicine

Resident in Internal Medicine

Postdoctoral Fellow

Co-Founder

Operations & BD Consultant

Director Of Operations

Product Development Manager

Orthopedic Research Assistant

Google Font API

Nginx

WordPress.org

Mobile Friendly

Android

Remote

Executive Administrative Assistant

Poxel is a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare disorders. Poxel has clinical and earlier-stage programs from its adenosine monophosphate-activated protein kinase (AMPK) activator and deuterated TZD platforms targeting chronic and rare metabolic diseases. For the treatment of NASH, PXL065 (deuterium-stabilized R-pioglitazone) is in a streamlined Phase 2 trial (DESTINY1). PXL770, a first-in-class direct AMPK activator, has successfully completed a Phase 2a proof-of-concept trial for the treatment of NASH, which met its objectives. For the rare inherited metabolic disorder, adrenoleukodystrophy (ALD), the company intends to initiate Phase 2a proof of concept studies with PXL065 and PXL770 in patients with adrenomyeloneuropathy (AMN). TWYMEEG® (Imeglimin), Poxel's first-in-class lead product that targets mitochondrial dysfunction, has been approved and launched for the treatment of type 2 diabetes in Japan. Poxel expects to receive sales-based payments and royalties from Sumitomo Dainippon Pharma. Poxel has a strategic partnership with Sumitomo Dainippon Pharma for Imeglimin in Japan, China, South Korea, Taiwan and nine other Southeast Asian countries. The Company intends to generate further growth through strategic partnerships and pipeline development. Listed on Euronext Paris, Poxel is headquartered in Lyon, France, and has subsidiaries in Boston, MA, and Tokyo, Japan.

POXEL

Microsoft Office 365

Amazon AWS

Apache

Data Analytics

Executive Assistant/Office Manager

At State Street, we partner with institutional investors all over the world to provide comprehensive financial services, including investment management, investment research and trading, and investment servicing. Whether you are an asset manager, asset owner, alternative asset manager, insurance company, pension fund or official institution, you can rely on us to be focused on your challenges. We are committed to doing what it takes to help you perform better — now and in the future.

Capital Management Analyst, Officer

Head of Asset Management Strategy, Managing Director

IT Business Analyst, AVP

State Street

Akamai

Melbourne IT

Drupal

Adobe Marketing Cloud

Assistant Vice President

Westbrook Partners, founded in April 1994, is a privately-owned, fully integrated real estate investment management company with offices in New York, Boston, Washington, DC, Palm Beach, San Francisco, Los Angeles, London, Paris and Tokyo.Westbrook's professionals are responsible for acquisition, value enhancement, financial accounting and risk management.Westbrook's experience includes the operation and management of office, multi-family residential, hotel, retail, industrial and single-family residential development properties.Westbrook's professionals have been among the world's most active and successful investors, having raised and invested approximately $10 billion of equity in $40 billion of real estate transactions in major markets throughout the world.Westbrook's investment equity is committed by a broad, stable base of the highest-quality institutional investors, which includes public and private pension funds, endowments, foundations, and financial institutions. Westbrook has full discretion over all investment decisions.

Melanie Skane

Executive Administrative Assistant at Glyscend Therapeutics

Melanie Skane's Professional Contact Details

Melanie Skane's Current Company Details

Glyscend Therapeutics

Melanie Skane's Work History and Education

Frequently Asked Questions about Melanie Skane

What company does Melanie Skane work for?

What is Melanie Skane's role at Glyscend Therapeutics?

What is Melanie Skane's email address?

What is Melanie Skane's business email address?

What is Melanie Skane's direct mobile number?

What industry does Melanie Skane work in?

Who are Melanie Skane's colleagues?

Colleagues at Glyscend Therapeutics

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?